Serum ceruloplasmin-ferroxidase activity in bipolar disorder is elevated compared to major depressive disorder and schizophrenia: a controlled study
OBJECTIVE: In this study, we aimed to study copper metabolism in schizophrenia, bipolar disorder, major depression compared with healthy control. METHODS: This is a single-centered cross-sectional study. The patients with schizophrenia (n = 36), bipolar disorder (n = 37), major depression (n = 40),...
Main Authors: | Serhat Tunç, Murat İlhan Atagün, Hamit Serdar Başbuğ, Özcan Erel |
---|---|
Format: | Article |
Language: | English |
Published: |
AVES
2019-07-01
|
Series: | Psychiatry and Clinical Psychopharmacology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/24750573.2019.1584489 |
Similar Items
-
Production of Recombinant Human Ceruloplasmin: Improvements and Perspectives
by: Maria Carmela Bonaccorsi di Patti, et al.
Published: (2021-07-01) -
Ceruloplasmin and Hypoferremia: Studies in Burn and Non-Burn Trauma Patients
by: Michael A. Dubick, et al.
Published: (2015-03-01) -
Ischemia-modified albumin: a unique marker of global metabolic risk in schizophrenia and mood disorders
by: Serhat Tunç, et al.
Published: (2019-04-01) -
Effects of Dietary Glucose and Fructose on Copper, Iron, and Zinc Metabolism Parameters in Humans
by: Nathaniel H. O. Harder, et al.
Published: (2020-08-01) -
Multi-Copper Oxidases and Human Iron Metabolism
by: Ross T. A. MacGillivray, et al.
Published: (2013-06-01)